Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShort-Term Debt repayments
Ratios

Gain Therapeutics (GANX) Receivables - Other (2021 - 2025)

Gain Therapeutics has reported Receivables - Other over the past 4 years, most recently at $517094.0 for Q3 2025.

  • Quarterly results put Receivables - Other at $517094.0 for Q3 2025, changed N/A from a year ago — trailing twelve months through Sep 2025 was $517094.0 (changed N/A YoY), and the annual figure for FY2024 was $494684.0, changed.
  • Receivables - Other for Q3 2025 was $517094.0 at Gain Therapeutics, down from $1.1 million in the prior quarter.
  • Over the last five years, Receivables - Other for GANX hit a ceiling of $1.1 million in Q2 2025 and a floor of $81862.0 in Q4 2021.
  • Median Receivables - Other over the past 4 years was $298300.0 (2022), compared with a mean of $389149.1.
  • Peak annual rise in Receivables - Other hit 6.8% in 2022, while the deepest fall reached 6.8% in 2022.
  • Gain Therapeutics' Receivables - Other stood at $81862.0 in 2021, then grew by 6.8% to $87430.0 in 2022, then soared by 465.81% to $494684.0 in 2024, then increased by 4.53% to $517094.0 in 2025.
  • The last three reported values for Receivables - Other were $517094.0 (Q3 2025), $1.1 million (Q2 2025), and $638961.0 (Q1 2025) per Business Quant data.